Clinical Trials Browser

Active not recruiting × Pancreatic Neoplasms × budigalimab × Clear all

NCT06119217 2024-12-04

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Phase 2 Active not recruiting

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms